BIORELIX INC

Profile

Company Names

BIORELIX INC

Addresses

5 SCIENCE PARK, 401 WINCHESTER AVENUE, NEW HAVEN, CT 06511

Phone Numbers

203.785.9282

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$14,137,380.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2012-03-02 
$2,558,096.00 
$2,558,096.00 
$0.00 
Debt 
3
2011-08-24 
$3,644,085.00 
$5,310,886.00 
$1,666,801.00 
Equity 
2
2010-12-14 
$2,400,000.00 
$4,800,000.00 
$2,400,000.00 
Debt 
1
2009-07-09 
$5,535,199.00 
$7,492,835.00 
$1,957,636.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PHILIPE 
 
CHAMBON 
DIRECTOR
BIORELIX INC
PHILIPPE 
 
CHAMBON 
DIRECTOR
VAXINNATE CORP   |  ARTISAN PHARMA, INC.   |  BIORELIX INC   |  TRUVERIS, INC.   |  QPID, INC.   |  PS25 LLC
PHILLIPE 
 
CHAMBON 
DIRECTOR
BIORELIX INC
BRIAN 
R. 
DIXON, PH.D 
EXECUTIVE OFFICER, DIRECTOR
BIORELIX INC
DOV 
 
GOLDSTEIN 
DIRECTOR
CEMPRA HOLDINGS, LLC   |  BIORELIX INC   |  ESPERION THERAPEUTICS, INC.   |  CEMPRA, INC.   |  LOXO ONCOLOGY, INC.   |  GEOM THERAPEUTICS, INC.   |  COYA THERAPEUTICS, INC.   |  NEUBASE THERAPEUTICS, INC.   |  BIOAGE LABS, INC.
RONALD 
 
LENNOX 
EXECUTIVE OFFICER, DIRECTOR
PRIMERADX, INC.   |  BIORELIX INC   |  OCTAGON THERAPEUTICS, INC.
JONATHAN 
M. 
LOURIE 
EXECUTIVE OFFICER
BIOTROVE, INC.   |  BIORELIX INC   |  SAGE SCIENCE INC
CAMPBELL 
 
MURRAY 
DIRECTOR
ALIOS BIOPHARMA INC   |  TOKAI PHARMACEUTICALS INC   |  AILERON THERAPEUTICS INC   |  BIORELIX INC   |  EUTHYMICS BIOSCIENCE INC   |  AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  IMAGINAB, INC.   |  GALERA THERAPEUTICS, INC.   |  BIONANO GENOMICS, INC   |  EUTHYMICS BIOSCIENCE, INC.   |  ICEBREAKER HEALTH, INC.   |  ANNEXON, INC.   |  TSCAN THERAPEUTICS, INC.   |  RENOVACOR, INC.   |  LIGHTHOUSE PHARMACEUTICALS, INC.
A. 
DONNY 
STROSBERG 
DIRECTOR
BIORELIX INC
A. DONNY 
 
STROSBERG 
DIRECTOR
BIORELIX INC
WILLIAM 
 
WIESLER 
DIRECTOR
BIORELIX INC   |  ARTIZAN BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-03-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-02 
2011-09-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-24 
2010-12-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-12-14 
2010-01-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-09 
2009-07-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#